31 October 2025
Johnson & Johnson Seeks FDA Approval for STELARA in Pediatric Ulcerative Colitis
sBLA submitted for STELARA to treat pediatric ulcerative colitis, backed by Phase 3 UNIFI Jr trial data, aiming to expand treatment options for children.
